is glp-1 an incretin The Impact: a new era in metabolic disease and obesity drug development Sistema incretina | GLP-1 y

All information presented on this website is for educational purposes only

The simple answer is that nobody knows

Novo Nordisk NVO Fair Value Estimate: $86.00 Morningstar Rating: 2 stars Morningstar Economic Moat Rating: Wide Morningstar Uncertainty Rating: High Novo Nordisk reported constant currency sales growth of 24% in the first quarter, in line with the 25% constant currency sales growth assumption we had built into our model for 2024

Even if youre using a GLP-1 RA primarily to manage diabetes, weight loss is common, and along with it, some muscle mass loss is likely to occur

doi:10.1080/09168451.2019.1697196 Zbidi H, Salido S, Altarejos J, et al